1. EachPod

KWS Saat SE CFO Eva Kienle - genome editing, global joint venture strategy & KWS R&D projects

Author
Prof. Dr. Serden Ozcan, Prof. Dr. Martin Glaum, Gori von Hirschhausen
Published
Wed 06 Apr 2022
Episode Link
https://pwc-leading-corporate-transformation.podigee.io/9-neue-episode

with Eva Kienle, CFO and Executive Board Member at KWS Saat SE & Co. KGaA

In this episode of Leading Corporate Transformation, Professor Martin Glaum from WHU and Gori von Hirschhausen from PwC Germany talk to Eva Kienle, CFO and Executive Board Member at seed producer KWS Saat. We cover a variety of topics, including challenges faced by companies in the agricultural sector and how global population growth will affect demand for seed solutions in the medium term and the long term. Kienle sees the pressure to innovate as a solution and an opportunity, both for KWS and the industry as a whole. She explains why this pressure is only going to increase in the next few years, and why genome editing is the new kid on the block. Kienle also talks about KWS’s own investment strategy, and explains why a certain level of perseverance helps with revenue planning in the seed industry.


Language: English

Share to: